Also trades as: 0LUS.L (LSE) · $vol 0M

$226.72

-13.89 (-5.77%)

After Hours: $226.50 (-0.22, -0.09%)

Weekly Expected Move ±2.7%

$224 $231 $237 $244 $250

NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Neutral · Power 65 · $173.4B mcap · 720M float · 0.407% daily turnover · Short 68% of daily vol

Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: $909.4M held by 326 funds, 51 bp over Treasuries → details ▾

Not rated: lending and leverage are a financial company's business, which the model misreads.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$10.7B +35.8% ▲

5Y CAGR: +18.4%

Gross Profit

$4.2B +38.2% ▲

5Y CAGR: +16.0%

Operating Income

$355M -69.0% ▼

5Y CAGR: -13.4%

Net Income

$937M -1.6% ▼

5Y CAGR: -0.9%

EPS (Diluted)

$1.39 -11.5% ▼

5Y CAGR: -9.8%

EBITDA

$2.3B -16.8% ▼

5Y CAGR: +8.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.7B	$5.8B	$6.5B	$7.9B	$10.7B
YoY Growth	+2.7%	+22.6%	+12.2%	+21.2%	+35.8%
Cost of Revenue	$2.8B	$3.6B	$3.9B	$4.8B	$6.5B
Gross Profit	$1.9B	$2.2B	$2.5B	$3.0B	$4.2B
Gross Margin	41.1%	38.4%	39.1%	38.5%	39.2%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$127M	$150M	$179M	$235M	$1.7B
Operating Expenses	$1.2B	$1.5B	$1.6B	$1.9B	$3.8B
Operating Income	$763M	$746M	$940M	$1.1B	$355M
Operating Margin	16.2%	12.9%	14.5%	14.6%	3.3%
Interest Expense	$490M	$530M	$608M	$574M	$652M
Income Before Tax	$383M	$168M	$365M	$976M	$955M
Tax Expense	$9M	$7M	$6M	$3M	-$7M
Net Income	$336M	$141M	$340M	$952M	$937M
Net Margin	7.1%	2.4%	5.2%	12.1%	8.8%
EPS (Diluted)	$0.78	$0.30	$0.66	$1.57	$1.39
EBITDA	$1.7B	$2.0B	$2.4B	$2.8B	$2.3B
Shares Outstanding	427M	465M	519M	609M	680M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$2.2B	$2.4B	$2.5B	$2.6B	$3.1B	$3.3B	$3.5B	$3.7B
Cost of Revenue	$1.4B	$1.5B	$1.5B	$1.6B	$1.9B	$2.1B	$2.2B	$2.2B
Gross Profit	$810M	$926M	$1.0B	$1.1B	$1.2B	$1.3B	$1.4B	$1.5B
Gross Margin	36.5%	38.8%	39.8%	40.0%	38.3%	37.8%	39.3%	39.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$49M	$64M	$64M	$63M	$1.6B	$67M	$67M	$67M
Operating Expenses	$529M	$548M	$558M	$574M	$2.1B	$692M	$805M	$932M
Operating Income	$281M	$379M	$443M	$477M	-$944M	$558M	$589M	$537M
Operating Margin	12.7%	15.8%	17.6%	18.1%	-30.1%	16.9%	16.6%	14.5%
Interest Expense	$154M	$145M	$141M	$162M	$204M	$193M	$182M	$193M
Income Before Tax	$124M	$252M	$306M	$285M	$113M	$764M	$320M	$422M
Tax Expense	$114K	-$6M	$1M	$2M	-$5M	$12M	$62M	$7M
Net Income	$120M	$258M	$302M	$281M	$96M	$729M	$240M	$397M
Net Margin	5.4%	10.8%	12.0%	10.7%	3.1%	22.0%	6.8%	10.7%
EPS (Diluted)	$0.19	$0.40	$0.45	$0.40	$0.14	$1.02	$0.33	$0.54
EBITDA	$748M	$843M	$948M	$979M	-$459M	$1.2B	$1.3B	$1.3B
Shares Outstanding	634M	654M	668M	685M	710M	726M	732M	755M

WELL NYSE